KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Total Assets Over TimeStrong
Percentile Rank92
3Y CAGR+7.1%
5Y CAGR+22.1%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+7.1%/yr
vs +35.0%/yr prior
5Y CAGR
+22.1%/yr
Recent deceleration
Acceleration
-27.9pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$250.77M+6.5%
2024$235.40M+28.5%
2023$183.20M-10.1%
2022$203.88M-25.0%
2021$272.01M+194.0%
2020$92.53M-21.7%
2019$118.13M+92.4%
2018$61.39M+78.7%
2017$34.34M+38.8%
2016$24.75M-